Evidera
Sherry Wu is a seasoned Research Scientist and Manager specializing in Modeling and Simulation at Evidera since August 2016, where responsibilities include designing health economic evaluations and managing project progress across multiple healthcare interventions. Previous experience includes roles as a Research Analyst Intern at the World Health Organization, conducting cost-effectiveness studies for vaccine integration, and supporting health policy initiatives, as well as an internship with the New York City Department of Health focusing on breastfeeding services. Additional contributions were made as a Legislative Session Intern with Planned Parenthood VOTES Northwest and as a Research Assistant in various projects aimed at enhancing public health. Sherry Wu holds a Master of Public Health in Epidemiology from Columbia University and a Bachelor of Science in Public Health from the University of Washington.
This person is not in any teams
This person is not in any offices
Evidera
1 followers
Evidera is a business within Pharmaceutical Product Development, LLC, (PPD) a leading global contract research organization (CRO), and is the preeminent provider of evidence-based solutions to demonstrate the real-world effectiveness, safety, and value of biopharmaceutical and biotechnology products from early development through loss of exclusivity. We provide integrated scientific expertise and global operational capabilities to help you generate the evidence needed to optimize the market access and commercial potential of your products. Evidera was acquired by PPD in 2016 and originally created in 2013 as an independent company under the ownership of Symphony Technology Group following the acquisition of long-standing health economics, outcomes research, market access, epidemiology, and data analytics practices from United BioSource Corporation (UBC). Evidera has over 30 years of leadership and experience and its legacy brands include MEDTAP, Caro Research, Abt Bio-Pharmaceutical Solutions, MetaWorks, Total Healthcare Group, and Archimedes.